Alfa Cytology offers comprehensive guidelines for the development of breast cancer 3D spheroid models, designed to support researchers in accurately simulating the tumor microenvironment. With our advanced technology platform and customized solutions, we help accelerate the progress of breast cancer research and therapeutic development.
Advanced 3D Culture Technology | We utilize state-of-the-art 3D spheroid culture techniques that closely mimic the growth and behavior of breast cancer cells, ensuring high reproducibility and accuracy in experimental results. |
Optimized Drug Screening Platform | Our 3D models are optimized for cancer drug screening, providing a more realistic reflection of in vivo drug responses, and accelerating the drug discovery process. |
Customized Solutions | We offer tailored solutions based on the specific needs of each client, ensuring that the 3D model development aligns perfectly with the research goals. |
Comprehensive Technical Support | Our expert team provides full technical support throughout the project, from model development to data analysis, ensuring seamless execution. |
Download our comprehensive guidelines to explore how 3D spheroid models can advance your breast cancer research. For personalized services or further technical assistance, contact us to receive customized solutions tailored to your research needs.
3D Tumor Model for Breast Cancer
A homogeneous and uniformly sized 3D tumor sphere model was successfully formed by subjecting MDA-MB-231 breast cancer cells to static culture for 4-7 days (Fig.1). This emerging 3D culture technique provides a more physiologically representative model of breast cancer. The observed increase in spheroid size over time confirmed that the cells remained viable and proliferating within the model (Fig.2).
Fig.1 The MDA-MB-231 cell suspension was subjected to static culture for 4-7 days, resulting in the formation of a homogeneous and uniformly sized 3D sphere model. Scale bar: 200 μm.
Fig. 2 Relative viability over days of MDA-MB-231 spheroids.